Of Drug Administration, War and Oïkos: Mediating Cancer with Nanomedicines

References

• Loeve S . La notion d’objet rélationnel dans les nanotechnologies (avec et après Simondon) . In : Cahiers Simondon (numéro 6) . BarthélémyJH ( Ed. ). L’Harmattan , Paris, France , 47 – 109 ( 2015 ).
   Google Scholar
• Schillmeier M . What ELSI/A makes big and small in nanotechnology research . In : Absence in Science, Security and Policy. From Research Agendas to Global Strategy . RappertB , BalmerB ( Eds ). Palgrave Macmillan , London, UK , 55 – 77 ( 2015 ).
   Google Scholar
• Schillmeier M . Caring for social complexity in nanomedicine . Nanomedicine10 ( 20 ), 3181 – 3193 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Rasmussen A . Les enjeux d’une histoire des formes pharmaceutiques: La galénique, l’officine et l’industrie (XIXe–début XXe siècle) . Entreprises et histoire36 ( 2 ), 12 – 28 ( 2004 ).
   Google Scholar
• Bawa R . Nanoparticle-based therapeutics in humans: a survey . Nanotech. L. Bus.5 , 135 – 155 ( 2008 ).
   Google Scholar
• te Kulve H , RipA . Economic and societal dimensions of nanotechnology-enabled drug delivery . Expert Opin. Drug Del.10 ( 5 ), 611 – 622 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Vauthier C , BochotA , CouvreurP . Vers une nouvelle galénique: au chevet du médicament . Biofutur240 , 22 – 25 ( 2004 ).
   Google Scholar
• DiMasi JA , HansenRW , GrabowskiHG . The price of innovation: new estimates of drug development cost . J. Health Econ.22 ( 2 ), 151 – 185 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Paul SM , MytelkaDS , DunwiddieCTet al. How to improve R&D productivity: the pharmaceutical industry’s grand challenge . Nat. Rev. Drug Discov.9 ( 3 ), 203 – 214 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Meyer UA . Pharmacogenetics and adverse drug reactions . Lancet356 ( 9242 ), 1667 – 1671 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Downing GJ . Key aspects of health care on the path to personalized medicine . Transl. Res.154 ( 6 ), 272 – 276 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Guchet X . What’s in a word? The person of personalized (nano)medicine . Nanomedicine10 ( 20 ), 3167 – 3179 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Karatas H , AktasY , Gursoy-OzdemirYet al. A nanomedicine transports a peptide caspase-3 inhibitor across the blood–brain barrier and provides neuroprotection . J. Neurosci.29 ( 44 ), 13761 – 13769 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gabathuler R . Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases . Neurobiol. Dis.37 ( 1 ), 48 – 57 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Boussif O , Lezoualc’hF , BehrJPet al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine . Proc. Natl Acad. Sci. USA92 ( 16 ), 7297 – 7301 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Ryadnov M ( Ed. ). Bionanodesign: Following Nature’s Touch . Royal Society of Chemistry (No. 7) , London, UK ( 2009 ).
   Google Scholar
• Loeve S , NormandM . How to trust a molecule? The case of cyclodextrins entering the nanorealm . In : Quantum Engagements. Social Reflections of Nanoscience and Emerging Technologies . ZülsdorfT , CoenenC , FerrariAet al. Eds ). Akademische Verlagsgesellschaft , Heidelberg, Germany , 195 – 216 ( 2011 ).
   Google Scholar
• Shenai M . ‘Yotta-detection’ and ‘nano-destruction’: emerging innovations in the fight against cancer . Mich. Med. J.4 ( 1 ), 35 ( 2003 ).
   Google Scholar
• Franzen S , LommelSA . Targeting cancer with ‘smart bombs’: equipping plant virus nanoparticles for a ‘seek and destroy’ mission . Nanomedicine4 ( 5 ), 575 – 588 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Prabhu M , MutnuriS , DubeySK , NaikMM . One-pot rapid synthesis of face-centered cubic silver nanoparticles using fermented cow urine, a nanoweapon against fungal and bacterial pathogens . J. Bionanosci.8 ( 4 ), 265 – 273 ( 2014 ).
   Google Scholar
• Sun Q , WangQ , RaoBK , JenaP . Electronic structure and bonding of Au on a SiO2 cluster: a nanobullet for tumors . Phys. Rev. Lett.93 ( 18 ), 186803 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Sarkar D , SpencerJA , PhillipsJAet al. Engineered cell homing . Blood118 ( 25 ), e184 – e191 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y . Stealth liposomes: the silent nanobombers . Preclinical Formulation4 , 19 – 24 ( 2008 ).
   Google Scholar
• Strebhardt K , UllrichA . Paul Ehrlich’s magic bullet concept: 100 years of progress . Nat. Rev. Cancer8 ( 6 ), 473 – 480 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Montgomery SL . The Scientific Voice . Guilford Press , NY, USA ( 1996 ).
   Google Scholar
• Nerlich B . Biomilitarism and nanomedicine: evil metaphors for the good of human health?http://luthscitech.org/biomilitarism-and-nanomedicine-evil-metaphors-for-the-good-of-human-health .
   Google Scholar
• Hodgkin P . Medicine is war: and other medical metaphors . BMJ291 ( 6511 ), 1820 – 1821 ( 1985 ).
   PubMedGoogle Scholar
• Montgomery SL . Codes and combat in biomedical discourse . Sci. Cult.2 ( 3 ), 341 – 391 ( 1991 ).
   Google Scholar
• Reisfield GM , WilsonGR . Use of metaphor in the discourse on cancer . J. Clin. Oncol.22 ( 19 ), 4024 – 4027 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Penson RT , SchapiraL , DanielsKJ , ChabnerBA , LynchTJ . Cancer as metaphor . Oncologist9 ( 6 ), 708 – 716 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Larson BM , NerlichB , WallisP . Metaphors and biorisks: the war on infectious diseases and invasive species . Sci. Commun.26 ( 3 ), 243 – 268 ( 2005 ).
   Web of Science ®Google Scholar
• Mongoven A . The war on disease and the war on terror: a dangerous metaphorical nexus? . Camb. Q Health. Ethic15 ( 04 ), 403 – 416 ( 2006 ).
   PubMedGoogle Scholar
• Camus JTW . Metaphors of cancer in scientific popularization articles in the British press . Discourse Stud.11 ( 4 ), 465 – 495 ( 2009 ).
   Web of Science ®Google Scholar
• Harrington KJ . The use of metaphor in discourse about cancer: a review of the literature . Clin. J. Oncol. Nurs.16 ( 4 ), 408 – 412 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Sontag S . Illness as Metaphor . Farrar, Straus & Giroux , NY, USA ( 1978 ).
   Google Scholar
• Martin E . Toward an anthropology of immunology: the body as nation state . Med. Anthropol. Q.4 ( 4 ), 410 – 426 ( 1990 ).
   Web of Science ®Google Scholar
• Esposito R . Immunitas: The Protection and Negation of Life . Polity Press , Cambridge, UK ( 2011 ).
   Google Scholar
• Faguet G . The Conquest of Cancer: A Distant Goal . Springer , Dordrecht, The Netherlands ( 2014 ).
   Google Scholar
• Annas GJ . Reframing the debate on health care reform by replacing our metaphors . N. Engl. J. Med.332 ( 11 ), 744 – 747 ( 1995 ).
   PubMed Web of Science ®Google Scholar
• Olson JS . Making Cancer History: Disease and Discovery at the University of Texas MD Anderson Cancer Center . John Hopkins University Press , MD, USA ( 2011 ).
   Google Scholar
• Ehrlich P . Address delivered at the Dedication of the Georg-Speyer-Haus. 1906 . In : The Collected Papers of Paul Ehrlich . HimmelweitF ( Ed. ), Pergamon Press , London, UK , 53 – 63 ( 1960 ).
   Google Scholar
• De Kruif P . Microbe Hunters . Harcourt, Brace and Comp., Inc.NY, USA ( 1926 ).
   Google Scholar
• Stern F . Paul Ehrlich: the founder of chemotherapy . Angew. Chem. Int. Ed. Engl43 ( 33 ), 4254 – 4261 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Bensaude-Vincent B , LoeveS . Metaphors in nanomedicine: the case of targeted drug delivery . Nanoethics8 ( 1 ), 1 – 17 ( 2014 ).
   Web of Science ®Google Scholar
• Lakoff G , JohnsonM . Metaphors We Live By . University of Chicago Press , IL, USA ( 1980 ).
   Google Scholar
• Nerlich B . From Nautilus to Nanobo(a)ts: the visual construction of nanoscience . AZojonowww.azonano.com/article.aspx?ArticleID=1466 .
   Google Scholar
• Nerlich B . Powered by Imagination: nanobots at the science photo library . Sci. Cult.17 ( 3 ), 269 – 292 ( 2008 ).
   Google Scholar
• Austin JL . How to Do Things with Words . Clarendon Press , Oxford, UK ( 1962 ).
   Google Scholar
• Galison P . The ontology of the enemy: Norbert Wiener and the cybernetic vision . Crit. Inquiry21 ( 1 ), 228 – 266 ( 1994 ).
   Web of Science ®Google Scholar
• Choi KY , LiuG , LeeS , ChenX . Theranostic nanoplatforms for simultaneous cancer imaging and therapy: current approaches and future perspectives . Nanoscale4 ( 2 ), 330 – 342 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Caplan AL , EngelhardtHT , McCartneyJJ . Concepts of Health and Disease: Interdisciplinary Perspectives . Addison-Wesley , MA, USA ( 1981 ).
   Google Scholar
• Kwon IK , LeeSC , HanB , ParkK . Analysis on the current status of targeted drug delivery to tumors . J. Control. Release164 ( 2 ), 108 – 114 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Venditto VJ , SzokaFC . Cancer nanomedicines: so many papers and so few drugs!Adv. Drug Deliver. Rev.65 ( 1 ), 80 – 88 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Svenson S . Clinical translation of nanomedicine . Curr. Opin. Solid State Mater. Sci.16 ( 6 ), 287 – 294 ( 2012 ).
   Web of Science ®Google Scholar
• Wang RB , BillonePS , MullettWM . Nanomedicine in action: an overview of cancer nanomedicine on the market and in clinical trials . J. Nanomater.1 , 1 – 12 ( 2013 ).
   Google Scholar
• Anselmo AC , MitragotriS . A review of clinical translation of inorganic nanoparticles . AAPS J.17 ( 5 ), 1041 – 1054 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lammers T . Smart drug delivery systems: back to the future vs. clinical reality . Int. J. Pharm.454 ( 1 ), 527 – 529 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Narayan VA , MohwinckelM , PisanoG , YangM , ManjiHK . Beyond magic bullets: true innovation in health care . Nat. Rev. Drug Discov.12 ( 2 ), 85 – 86 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kostarelas K . Is it time to call a truce in the ‘battle against disease’?The Guardian ( 2013 ). www.theguardian.com/science/small-world/2013/nov/28/battle-disease-medicine-medical-research .
   Google Scholar
• Gibbs JB , OliffA . Pharmaceutical research in molecular oncology . Cell79 ( 2 ), 193 – 198 ( 1994 ).
   PubMed Web of Science ®Google Scholar
• Lobo NA , ShimonoY , QianD , ClarkeMF . The biology of cancer stem cells . Annu. Rev. Cell Dev. Biol.23 , 675 – 699 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Rodríguez-Paredes M , EstellerM . Cancer epigenetics reaches mainstream oncology . Nat. Med.17 ( 3 ), 330 – 339 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Carmeliet P , JainRK . Angiogenesis in cancer and other diseases . Nature407 ( 6801 ), 249 – 257 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Visvader JE , LindemanGJ . Cancer stem cells in solid tumours: accumulating evidence and unresolved questions . Nat. Rev. Cancer8 ( 10 ), 755 – 768 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Laplane L . Stemness ontology and therapeutic strategies . CAPE Studies in Applied Philosophy Ethics Series1 , 77 – 99 ( 2012 ).
   Google Scholar
• Stacey J . Teratologies: A Cultural Study of Cancer . Routledge, London, UK ( 2013 ).
   Google Scholar
• Lorde A . The Cancer Journals . Aunt Lute , CA, USA ( 1980 ).
   Google Scholar
• Hodgkin P . Medicine is war: and other medical metaphors . BMJ291 ( 6511 ), 1820 – 1821 ( 1985 ).
   PubMedGoogle Scholar
• Simonton OC , SimontonS , CreightonJ . Getting Well Again: A Step-By-Step, Self-Help Guide To Overcoming Cancer For Patients And Their Families . Tarcher , CA, USA ( 1978 ).
   Google Scholar
• Mitchell GJ , Ferguson-ParéM , RichardsCJ . Exploring an alternative metaphor for nursing: Relinquishing military images and language . In : Philosophical and Theoretical Perspectives for Advanced Nursing Practice . CodyWK ( Ed. ). John & Barlett , MA, USA , 267 – 278 ( 2011 ).
   Google Scholar
• Sullivan M . In what sense is contemporary medicine dualistic? . Cult. Med. Psychiat.10 ( 4 ), 331 – 350 ( 1986 ).
   PubMed Web of Science ®Google Scholar
• Mol A , LawJ . Embodied action, enacted bodies: the example of hypoglycaemia . Body Soc.10 ( 2–3 ), 42 – 62 ( 2004 ).
   Google Scholar
• Levin T , KissaneDW . Psychooncology: the state of its development in 2006 . Eur. J. Psychiatry20 ( 3 ), 183 – 197 ( 2006 ).
   Web of Science ®Google Scholar
• Ehrenreich B . Smile! You’ve got cancer . The Guardian ( 2010 ). www.theguardian.com/lifeandstyle/2010/jan/02/cancer-positive-thinking-barbara-ehrenreich .
   Google Scholar
• Watson M , HavilandJ , GreerS , DavidsonJ , BlissJ . Influence of psychological response on survival in breast cancer: a population-based cohort study . Lancet354 , 1331 – 1336 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Lemon J , EdelmanS , KidmanAD . Perceptions of the ‘Mind-Cancer’ relationship by members of the public, cancer patients and oncologists . J. Psychosoc. Oncol.21 ( 4 ), 43 – 58 ( 2004 ).
   Web of Science ®Google Scholar
• Petticrew M , BellR , HunterD . Influence of psychological coping on survival and recurrence in people with cancer: systematic review . BMJ325 ( 7372 ), 1066 – 1076 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Garssen B . Psychological factors and cancer development: evidence after 30 years of research . Clin. Psychol. Rev.24 ( 3 ), 315 – 338 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Coyne JC , TennenH . Positive psychology in cancer care: bad science, exaggerated claims, and unproven medicine . Ann. Behav. Med.39 ( 1 ), 16 – 26 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Coyne JC , PajakTF , HarrisJet al. Emotional well-being does not predict survival in head and neck cancer patients . Cancer110 ( 11 ), 2568 – 2575 ( 2010 ).
   Google Scholar
• Satin JR , LindenW , PhillipsMJ . Depression as a predictor of disease progression and mortality in cancer patients . Cancer115 ( 22 ), 5349 – 5361 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Nakaya N , BidstrupPE , Saito-NakayaKet al. Personality traits and cancer risk and survival based on Finnish and Swedish registry data . Am. J. Epidemiol.172 ( 4 ), 377 – 385 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ranchor AV , SandermanR , CoyneJC . Invited commentary: personality as a causal factor in cancer risk and mortality – time to retire a hypothesis? . Am. J. Epidemiol.172 ( 4 ), 386 – 388 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Al-Saleem T . Let’s find another metaphor for ‘The War on Cancer’ . Oncology Times29 ( 6 ), 9 ( 2007 ).
   Google Scholar
• Hauser D , WasserungR . Do we need to end the ‘war’ on cancer?The Guardian ( 2015 ). www.theguardian.com/commentisfree/2015/mar/22/saying-youre-fighting-a-war-on-cancer-could-make-you-lose-it .
   Google Scholar
• McCartney M . The fight is on: military metaphors for cancer may harm patients . BMJ349 , g5155 ( 2014 ).
   PubMedGoogle Scholar
• Granger K . Having cancer is not a fight or a battle . The Guardian ( 2014 ). www.theguardian.com/society/2014/apr/25/having-cancer-not-fight-or-battle .
   Google Scholar
• Rappert B , BalmerB ( Eds ). Absence in Science, Security and Policy. From Research Agendas to Global Strategy . Palgrave Macmillan , London, UK ( 2015 ).
   Google Scholar
• Hofmann BM . The technological invention of disease . Med. Hum.27 ( 1 ), 10 – 19 ( 2001 ).
   PubMedGoogle Scholar
• Nichols JW , BaeYH . Odyssey of a cancer nanoparticle: from injection site to site of action . Nano Today7 ( 6 ), 606 – 618 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Gazeau F , AlloyeauD , PellegrinoT . The life-cycle of nanomaterials in the (bio)environment: impact on physical properties and toxicity issue . Presented at : Paris Condensed Matter Conference . Paris, France , 14–29 August 2014 .
   Google Scholar
• Gabizon AA . Pegylated liposomal doxorubicin: metamorphosis of an old drug into a new form of chemotherapy . Cancer Invest.19 ( 4 ), 424 – 436 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Couvreur P , KanteB , GrislainL , RolandM , SpeiserP . Toxicity of polyalkylcyanoacrylate nanoparticles II: doxorubicin-loaded nanoparticles . J. Pharm. Sci.71 ( 7 ), 790 – 792 ( 1982 ).
   PubMed Web of Science ®Google Scholar
• Loeve S , Bensaude-VincentB , GazeauF . Nanomedicine metaphors: from war to care. Emergence of an oecological approach . Nano Today8 ( 6 ), 560 – 565 ( 2013 ).
   Web of Science ®Google Scholar
• Simondon G . Du mode d’éxistence des objets techniques . Aubier , Paris, France ( 1958 ).
   Google Scholar
• Lynch I , DawsonKA . Protein-nanoparticle interactions . Nano Today3 ( 1 ), 40 – 47 ( 2008 ).
   Web of Science ®Google Scholar
• Monopoli MP , ÅbergC , SalvatiA , DawsonKA . Biomolecular coronas provide the biological identity of nanosized materials . Nat. Nanotechnol.7 ( 12 ), 779 – 786 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Walkey CD , ChanWC . Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment . Chem. Soc. Rev.41 ( 7 ), 2780 – 2799 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Tenzer S , DocterD , KuharevJet al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology . Nat. Nanotechnol.8 ( 10 ), 772 – 781 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Fadeel B , FeliuN , VogtC , AbdelmonemAM , ParakWJ . Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials . Wiley Inter. Rev. Nanomed. Nanobiotechnol.5 ( 2 ), 111 – 129 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Albanese A , WalkeyCD , OlsenJB , GuoH , EmiliA , ChanWC . Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles . ACS Nano8 ( 6 ), 5515 – 5526 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Gunawan C , LimM , MarquisCP , AmalR . Nanoparticle–protein corona complexes govern the biological fates and functions of nanoparticles . J. Mat. Chem. B2 ( 15 ), 2060 – 2083 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bhattacharya K , FarcalL , FadeelB . Shifting identities of metal oxide nanoparticles: focus on inflammation . MRS Bulletin39 ( 11 ), 970 – 975 ( 2014 ).
   Web of Science ®Google Scholar
• Docter D , WestmeierD , MarkiewiczM , StolteS , KnauerSK , StauberRH . The nanoparticle biomolecule corona: lessons learned–challenge accepted?Chem. Soc. Rev.44 ( 17 ), 6094 – 6121 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Von Maltzahn G , ParkJH , LinKYet al. Nanoparticles that communicate in vivo to amplify tumour targeting . Nat. Mat.10 ( 7 ), 545 – 552 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Holme MN , FedotenkoIA , AbeggDet al. Shear-stress sensitive lenticular vesicles for targeted drug delivery . Nat. Nanotechnol.7 ( 8 ), 536 – 543 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Silva AK , Kolosnjaj-TabiJ , BonneauSet al. Magnetic and photoresponsive theranosomes: translating cell-released vesicles into smart nanovectors for cancer therapy . ACS Nano7 ( 6 ), 4954 – 4966 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Merlo LM , PepperJW , ReidBJ , MaleyCC . Cancer as an evolutionary and ecological process . Nat. Rev. Cancer6 ( 12 ), 924 – 935 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Gatenby RA . A change of strategy in the war on cancer . Nature459 ( 7246 ), 508 – 509 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Gatenby RA , BrownJ , VincentT . Lessons from applied ecology: cancer control using an evolutionary double bind . Cancer Res.69 ( 19 ), 7499 – 7502 ( 2009 ).
   PubMed Web of Science ®Google Scholar